Early in vivo CAR-T human data emerge from biotech trials in China
The first shards of human data on in vivo CAR-T cell therapy look promising, based on recent, separate reports from two biotech companies’ academic-led studies in China. Last week, a Chinese startup called Genocury became ...
The first shards of human data on in vivo CAR-T cell therapy look promising, based on recent, separate reports from two biotech companies’ academic-led studies in China.
Last week, a Chinese startup called Genocury became ...
